14 January 2022 : Database Analysis
H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation
Zongkuo Li12AE, Menglong Hu12A, Jinhuan Qiu12C, Junkai Feng12C, Ruizhen Zhang1C, Huifang Wu1D, Guiming Hu1D, Jingli Ren1G*DOI: 10.12659/MSM.933447
Med Sci Monit 2022; 28:e933447
Figure 4 The expression level of H2AFZ in subgroups of patients with LUAD. (A–C) The expression of H2AFZ is grouped by pathological stage, T, and N classification based on TCGA-LUAD data. (D) Differential mRNA expression of H2AFZ in LUAD with different T classifications in GSE68465. R 4.1.0 software (R Development Core Team, Vienna).